← Firms / Strategy
Investment strategy
Life Sciences / Medical Office
Life Sciences / Medical Office is pursued by 3 firms tracked on DataBane, spanning Real Estate. The largest tracked manager by assets is Nuveen at $1.4T. Profiles below cover each firm's mandate, focus areas, funds and relationships — updated as analysts publish new research.
3
Firms
0
Related funds
1
Asset classes
Asset-class mix
Insight
Most concentrated in Real Estate (3 of 3 firms). Nuveen is the largest tracked manager at $1.4T.
Firms pursuing this strategy
Geographic exposure
Europe15North America14Asia9Global2
Recent news
fundraise
KKR and Capital Group to Launch Public & Private Equity Fund
KKR · 30/07/2026
deal
Nuveen Energy Infrastructure Credit completes US$546 million preferred equity investment in SunZia.
Nuveen · 01/07/2026
strategy
KKR Expands European Insurance Strategy
KKR · 01/07/2026
leadership
L&G appoints Zoe Wimborne as Group Chief Risk Officer
Legal & General Investment Management (LGIM) · 10/06/2026
strategy
L&G’s Lifetime Advantage Funds reach £25bn and surpass 10% private markets allocation
Legal & General Investment Management (LGIM) · 20/05/2026
leadership
L&G appoints Rob Groves as Chief Investment Officer for Institutional Retirement business
Legal & General Investment Management (LGIM) · 05/05/2026
deal
Nuveen acquires Munich LEN Business Park
Nuveen · 20/04/2026
leadership
L&G appoints Emiel van den Heiligenberg as Chief Investment Officer for the Asset Management business
Legal & General Investment Management (LGIM) · 02/04/2026
other
Nuveen Reports US$1.4 Trillion in Total AUM as of 31 March 2026
Nuveen · 31/03/2026
strategy
Nuveen publishes sixth annual EQuilibrium Global Institutional Investor Survey
Nuveen · 04/02/2026